DELAWARE | 20-0422823 | |
(State or Other Jurisdiction of
Incorporation or Organization) |
(I.R.S. Employer
Identification No.) |
Large accelerated filer o | Accelerated filer o |
Non-accelerated filer
þ
(Do not check if a smaller reporting company) |
Smaller reporting company o |
Proposed | Proposed | |||||||||||||||||||||
Amount | Maximum | Maximum | Amount Of | |||||||||||||||||||
Title Of | To Be | Offering Price | Aggregate | Registration | ||||||||||||||||||
Securities To Be Registered | Registered (1) | Per Share (2) | Offering Price (2) | Fee | ||||||||||||||||||
Amended and Restated 2007 Equity
Incentive Plan
Common Stock (par value $0.01 per share) |
2,000,000 | $ | 9.86 | $ | 19,720,000 | $ | 775.00 | |||||||||||||||
2007 Director Option Plan
Common Stock (par value $0.01 per share) |
126,423 | $ | 9.86 | $ | 1,246,531 | $ | 4 9 . 0 0 | |||||||||||||||
TOTAL:
|
2,126,423 | $ | 20,966,531 | $ | 824.00 | |||||||||||||||||
(1) | In addition, pursuant to Rule 416(c) under the Securities Act of 1933, as amended, this Registration Statement also covers an indeterminate number of additional shares of common stock that may be offered or issued in the event of a stock dividend, reverse stock split, split-up, recapitalization, forfeiture of stock under those plans, or other similar event. | |
(2) | The proposed maximum offering price of $9.86 per share, which is the average of the high and low prices of the Registrants common stock as reported on the NASDAQ Global Market on February 3, 2009, is set forth solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and (h) under the Securities Act of 1933. |
(a) | The Registrants Annual Report on Form 10-K for the year ended December 31, 2008 filed on February 5, 2009; | ||
(b) | All other reports filed by the Registrant pursuant to Sections 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the Annual Report referred to in (a) above; and | ||
(c) | The section entitled Description of Registrants Securities to be Registered contained in the Registrants Registration Statement on Form 8-A (file No. 001-33497) filed with the Commission on May 23, 2007, pursuant to Section 12(b) of the Exchange Act, including any amendment or report filed for the purpose of updating such description. |
Exhibit | ||
Number | Exhibit Description | |
|
||
3.1(1)
|
Restated Certificate of Incorporation | |
|
||
3.2(2)
|
Amended and Restated By-laws | |
|
||
4.1(3)
|
Third Amended and Restated Investor Rights Agreement, dated as of September 13, 2006, as amended | |
|
||
5.1
|
Opinion of Bingham McCutchen LLP with respect to the legality of the shares being registered | |
|
||
23.1
|
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm | |
|
||
23.2
|
Consent of Bingham McCutchen LLP (included in Exhibit 5.1) | |
|
||
24
|
Power of Attorney (included in signature page hereto) |
(1) | Incorporated by reference to Exhibit 3.1 to the Registrants Registration Statement on Form S-1 (Commission File No. 333-141700) | |
(2) | Incorporated by reference to Exhibit 3.4 to the Registrants Registration Statement on Form S-1 (Commission File No. 333-141700) | |
(3) | Incorporated by reference to Exhibit 4.2 to the Registrants Registration Statement on Form S-1 (Commission File No. 333-141700) |
AMICUS THERAPEUTICS, INC.
|
||||
By: | /s/ John F. Crowley | |||
Name: | John F. Crowley | |||
Title: | President and Chief Executive Officer | |||
Signature | Title | |
|
||
/s/ John F. Crowley
|
President and Chief Executive Officer;
Director (Principal Executive Officer) |
|
|
||
/s/ James E. Dentzer
|
Chief Financial Officer and Treasurer
(Principal Accounting and Financial Officer) |
|
|
||
/s/ Donald J. Hayden
|
Director | |
|
||
/s/ Sol J. Barer, Ph.D.
|
Director | |
|
||
/s/ Alexander E. Barkas, Ph.D.
|
Director |
Signature | Title | |
|
||
/s/ Stephen Bloch, M.D.
|
Director | |
|
||
/s/ P. Sherrill Neff
|
Director | |
|
||
/s/ Michael G. Raab
|
Director | |
|
||
/s/ Glenn P. Sblendorio
|
Director | |
|
||
/s/ James N. Topper, M.D., Ph.D.
|
Director |
Exhibit Number
Exhibit Description
Restated Certificate of Incorporation
Amended and Restated By-laws
Third Amended and Restated Investor Rights Agreement, dated as of
September 13, 2006, as amended
Opinion of Bingham McCutchen LLP with respect to the legality of the
shares being registered
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
Consent of Bingham McCutchen LLP (included in Exhibit 5.1)
Power of Attorney (included in signature page hereto)
(1)
Incorporated by reference to Exhibit 3.1 to the Registrants Registration Statement on Form S-1
(Commission File No. 333-141700)
(2)
Incorporated by reference to Exhibit 3.4 to the Registrants Registration Statement on Form S-1
(Commission File No. 333-141700)
(3)
Incorporated by reference to Exhibit 4.2 to the Registrants Registration Statement on Form S-1
(Commission File No. 333-141700)
Very truly yours,
|
||||
/s/ Bingham McCutchen LLP | ||||
BINGHAM MCCUTCHEN LLP | ||||